Hormone Therapy for Menopause: What the Updated FDA Labels Mean
Blog Content:
For more than twenty years, hormone therapy for menopause came with the FDA's most prominent safety warning, and many women were told to avoid it. That guidance has changed. This article explains what the FDA updated, what stayed the same, and how to approach the decision and the cost with a licensed provider. It is educational and does not replace medical advice.
What the FDA changed
In November 2025, the FDA asked manufacturers of menopausal hormone therapy to revise their labeling. The agency requested the removal of boxed warning language about cardiovascular disease, breast cancer, and probable dementia. Revised labels for the first group of products were approved in early 2026, and more are being updated.
The reasoning is about timing. The original warning was based largely on a study of women who were, on average, well past menopause when they started treatment. Later analyses suggest the balance of benefits and risks is more favorable for women who begin before age 60 or within about ten years of their last period.
What did not change
The update is a correction in emphasis, not a declaration that hormone therapy is risk-free.
- The boxed warning about endometrial cancer remains for estrogen taken without a progestogen.
- Information about cardiovascular and breast cancer risks is still in the labeling, outside the boxed warning.
- Hormone therapy is still a prescription treatment that requires an individual review of your health history.
Who is usually considered a candidate
Hormone therapy is FDA-approved for moderate to severe hot flashes and night sweats, for vaginal symptoms of menopause, and for prevention of bone loss. Providers most often consider it for women who:
- Have symptoms that interfere with sleep, work, or daily life
- Are under 60 or within about ten years of menopause
- Have no condition that makes hormones unsafe for them
It is generally not recommended for women with a history of breast cancer or another hormone-sensitive cancer, blood clots, stroke, heart attack, active liver disease, or unexplained vaginal bleeding. Your provider will weigh these with you.
The main types
Systemic estrogen. Pills, patches, gels, and sprays that treat hot flashes and night sweats throughout the body.
Estrogen plus a progestogen. If you still have a uterus, systemic estrogen is prescribed together with a progestogen to protect the uterine lining.
Low-dose vaginal estrogen. Creams, tablets, or rings used locally for dryness and discomfort. Very little reaches the rest of the body.
Non-hormonal prescriptions. FDA-approved options exist for women who cannot or prefer not to take hormones.
The truth about "bioidentical" hormones
"Bioidentical" means a hormone has the same molecular structure as the one your body makes. It is a description, not a safety rating.
Two facts are often left out. First, several FDA-approved products already contain bioidentical estradiol and progesterone. Second, custom-compounded hormone preparations are not FDA-approved, and they have not been shown to be safer or more effective than approved products. If someone tells you a compounded formula carries fewer risks, ask what evidence supports that.
Do you need hormone testing first
Usually not as much as marketing suggests. For most women over 45 with typical symptoms, perimenopause and menopause are identified from symptoms and menstrual history. Hormone levels swing widely during perimenopause, so a single result can mislead, and saliva testing is not considered reliable.
A provider may still order blood work to rule out other causes of similar symptoms, such as a thyroid condition.
How to keep hormone therapy affordable
- Ask about generics. Generic versions of FDA-approved estradiol and progesterone are widely available and are often among the least expensive options.
- Check your coverage. Insurance plans commonly cover FDA-approved hormone therapy. Compounded preparations are frequently not covered.
- Compare formats. A pill, a patch, and a gel can differ considerably in price. Ask whether a lower-cost format suits your situation.
- Request a longer supply. A 90-day prescription often costs less per month than monthly refills.
- Skip tests you do not need. Large hormone panels sold directly to consumers add cost and rarely change the treatment decision.
- Use telehealth for follow-up. Online visits can reduce travel and time away from work when in-person care is not required.
Getting ready for the conversation
Before your visit, write down:
- Your symptoms, how often they occur, and how they affect you
- The date of your last period, or how your cycle has changed
- Whether you have had a hysterectomy
- Your personal and family history of breast cancer, blood clots, stroke, and heart disease
- Every medication and supplement you take
Next step
Menopause care is not one-size-fits-all, and the right plan depends on your history and your priorities. Nu Image Medical offers private online evaluations with licensed providers for women's health concerns. A provider can review your situation, explain which options are available through our programs, and tell you when in-person care is the better route.
This content is for educational purposes only and is not medical advice, diagnosis, or treatment. Prescription products require a consultation with a licensed healthcare provider, who will determine whether a prescription is appropriate. Compounded medications are not reviewed or approved by the FDA for safety, efficacy, or quality.
This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your physician about the risks and benefits of any treatment. Nu Image Medical may not offer the medications or services mentioned in this article.
